Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December

Core Insights - Teva Pharmaceutical Industries Ltd. will present at three investor conferences in December 2025, featuring CEO Richard Francis and other executive management [1][5] - The company is transitioning into a leading innovative biopharmaceutical firm, supported by a strong generics business, with a focus on neuroscience, immunology, complex generics, biosimilars, and pharmacy brands [3] Company Overview - Teva has been committed to improving health for over 120 years, emphasizing innovation and addressing patient needs [3] - The company aims to expand its innovative and biosimilar medicines pipeline while maintaining its generic medicines portfolio [4]